Cargando…

Prognostic Interactions between FAP+ Fibroblasts and CD8a+ T Cells in Colon Cancer

SIMPLE SUMMARY: In addition to malignant cells, tumors are composed also of other cell types including immune cells and fibroblasts. These cell types interact with each other and with the malignant cells. Prognosis associations have previously been demonstrated for CD8-positive immune cells. Recent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herrera, Mercedes, Mezheyeuski, Artur, Villabona, Lisa, Corvigno, Sara, Strell, Carina, Klein, Christian, Hölzlwimmer, Gabriele, Glimelius, Bengt, Masucci, Giuseppe, Sjöblom, Tobias, Östman, Arne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693786/ https://www.ncbi.nlm.nih.gov/pubmed/33153037 http://dx.doi.org/10.3390/cancers12113238

Ejemplares similares

Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort
por: Osterman, Erik, et al.
Publicado: (2020)

Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer
por: Mezheyeuski, Artur, et al.
Publicado: (2019)

Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome
por: Mezheyeuski, Artur, et al.
Publicado: (2020)

Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer
por: Mezheyeuski, Artur, et al.
Publicado: (2017)

Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer
por: Kilvaer, Thomas Karsten, et al.
Publicado: (2018)

Fibroblasts—a key host cell type in tumor initiation, progression, and metastasis
por: Strell, Carina, et al.
Publicado: (2012)

Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer
por: Mezheyeuski, Artur, et al.
Publicado: (2016)

A Comprehensive Evaluation of Associations Between Routinely Collected Staging Information and The Response to (Chemo)Radiotherapy in Rectal Cancer
por: Hammarström, Klara, et al.
Publicado: (2020)

Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer
por: Mezheyeuski, Artur, et al.
Publicado: (2016)

Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma
por: Frödin, Magnus, et al.
Publicado: (2017)

Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter- and intra-patient heterogeneity and impact on survival
por: Corvigno, Sara, et al.
Publicado: (2016)

APC(+/−) alters colonic fibroblast proteome in FAP
por: Patel, Bhavinkumar B., et al.
Publicado: (2011)

Vessel size as a marker of survival in estrogen receptor positive breast cancer
por: Milosevic, Vladan, et al.
Publicado: (2023)

Radioligands Targeting Fibroblast Activation Protein (FAP)
por: Lindner, Thomas, et al.
Publicado: (2021)

High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis
por: Wikberg, Maria L., et al.
Publicado: (2013)

The Immune Landscape of Colorectal Cancer
por: Mezheyeuski, Artur, et al.
Publicado: (2021)

Design, Synthesis and Preclinical Assessment of (99m)Tc-iFAP for In Vivo Fibroblast Activation Protein (FAP) Imaging
por: Trujillo-Benítez, Diana, et al.
Publicado: (2022)

Translational imaging of the fibroblast activation protein (FAP) using the new ligand [(68)Ga]Ga-OncoFAP-DOTAGA
por: Backhaus, P., et al.
Publicado: (2021)

A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis
por: Sjöberg, Elin, et al.
Publicado: (2018)

Fibroblast activation protein (FAP) as a novel metabolic target
por: Sánchez-Garrido, Miguel Angel, et al.
Publicado: (2016)

Recurrence Risk after Radical Colorectal Cancer Surgery—Less Than before, But How High Is It?
por: Osterman, Erik, et al.
Publicado: (2020)

Multi‐parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour‐type‐specific stroma phenotypes and a novel vascular biomarker
por: Corvigno, Sara, et al.
Publicado: (2017)

Selective Homogeneous Assay for Circulating Endopeptidase Fibroblast Activation Protein (FAP)
por: Bainbridge, Travis W., et al.
Publicado: (2017)

Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment
por: Lin, Yuli, et al.
Publicado: (2019)

Radiation-induced FAP + fibroblasts are involved in keloid recurrence after radiotherapy
por: Gao, Yan, et al.
Publicado: (2022)

Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC
por: Strell, Carina, et al.
Publicado: (2017)

Signet Ring Cell Colorectal and Appendiceal Cancer: A Small Signet Ring Cell Component Is Also Associated with Poor Outcome
por: Enblad, Malin, et al.
Publicado: (2023)

A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differentiation
por: Harryvan, T.J., et al.
Publicado: (2022)

Altered Tissue and Plasma Levels of Fibroblast Activation Protein-α (FAP) in Renal Tumours
por: Solano-Iturri, Jon Danel, et al.
Publicado: (2020)

Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma
por: Bughda, Reyisa, et al.
Publicado: (2021)

Could Fibroblast Activation Protein (FAP)-Specific Radioligands Be Considered as Pan-Tumor Agents?
por: Roustaei, Hessamoddin, et al.
Publicado: (2022)

Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy
por: Zboralski, Dirk, et al.
Publicado: (2022)

1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer
por: Mayrhofer, Markus, et al.
Publicado: (2014)

ASO Author Reflections: Emerging Risk Factors in Colon Cancer—End of the Line for Clinomics?
por: Osterman, Erik, et al.
Publicado: (2019)

High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer
por: Paulsson, Janna, et al.
Publicado: (2016)

Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trial
por: Strell, Carina, et al.
Publicado: (2021)

CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
por: Aasebø, Kristine, et al.
Publicado: (2020)

Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells
por: Sahlberg, Sara Häggblad, et al.
Publicado: (2014)

Change of offices for the FAP Department
por: FAP Department
Publicado: (2016)

Spheroids of FAP-Positive Cell Lines as a Model for Screening Drugs That Affect FAP Expression
por: Pleshkan, Victor V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5ru4kl9odc2f4a5onk1a760sh1